In summary, the PD1+CD28− CD11ahigh T-cell subset represents a highly differentiated, functional, and Ag-experienced population circulating in peripheral blood, which declines in the tumor, where the expression of CD11a still favors its functionality. The gene discussed is ITGAL; the disease is neoplasm.